Back

The efficacy and safety of simvastatin-fenofibrate fixed-dose combination in patients undergoing percutaneous coronary intervention

9 June 2018 (14:56 - 15:07)
Organised by:
Congress Presentation Part of: Oral abstract session: PPCI , risk factors and prevention Pharmacotherapy ACNAP Premium Access EuroHeartCare 2018

About the speaker

Photo
Doctor Bakhodir Narziev

Heart Team Clinic, Tashkent (Uzbekistan)

7 More presentations in this session

Presentation thumbnail
Advancing the management of type 2 diabetes through an integrated community based cardiovascular disease prevention programme
Ms I. Gibson (Galway, IE)
Abstract Slides
Presentation thumbnail
Patients' experience of risk communication after acute myocardial infarction: a meta-synthesis of qualitative studies
Doctor S. Mentrup (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Poor social network is associated with impaired self-rated health and symptoms of anxiety and depression across cardiac diagnoses.
Miss A. Vinggaard Christensen (Copenhagen, DK)
Abstract
Presentation thumbnail
Does depression affect outcomes in a clinical trial of a self-care cardiovascular disease risk reduction intervention conducted in a socioeconomically austere environment?
Professor D. Moser (Knoxville, US)
Abstract Slides
Presentation thumbnail
Combined use of a healthy lifestyle smartphone application and usual primary care counseling to improve arterial stiffness: A Randomized Controlled Trial (EVIDENT II Study).
Assistant Professor J. Recio-Rodriguez (Salamanca, ES)
Abstract

Access the full session

Session thumbnail
Oral abstract session: PPCI , risk factors and prevention

The Event

Event poster

EuroHeartCare 2018

9 June 2018 14:56 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources